The BioProcess International Conference and Exhibition has earned its reputation as the leading and largest bioprocessing-focused industry event. This year’s conference — 4–7 September 2018 at the Hynes Convention Center in Boston —
will attract more than 2,000 scientists and executives working across the entire spectrum of biopharmaceutical process development and manufacturing. Our mission is to provide their industry with the science, technologies, and connections they need to develop safe, effective and cost-efficient drugs for patients. Here you can network, learn, and catch up with colleagues while discovering tangible applications of the latest technical, scientific, and strategic innovations you need to accelerate promising biologics toward commercial success.
The multitrack agenda provides exclusive case studies and new data presentations for hyperfocused discussion by department, while bringing everyone together for plenary keynote sessions to keep the industry abreast of key trends and critical updates. Keynote presenters on this year’s agenda represent some of the brightest minds in bioprocessing, including
- Robert Langer (David H. Koch Institute professor at the Massachusetts Institute of Technology)
- Jason Walther (principal scientist in downstream bioprocess development at Sanofi)
- Thomas Seewoester (executive director of clinical drug substance manufacturing at Amgen)
- Elsie DeBella (vice president of biologics process and CMC development at Momenta Pharmaceuticals)
- E. Morrey Atkinson (vice president and head of internal commercial manufacturing for biologics at Bristol-Myers Squibb)
- Rebecca Sendak (US head of biopharmaceutics development at Sanofi).
Additionally, the exhibit hall features >200 technology suppliers and service providers who will be showcasing the latest products and technologies devoted to the biopharmaceutical community.
Capping this all off is our Biotech Week Boston Festival Party, the only place where you can kick back, have fun, and meet attendees from all of the official events that are part of Biotech Week Boston. Unwind, network in a great atmosphere, and enjoy an evening of rock and roll with a headline band.
BioProcess International is the official publication of this event and as such was pleased to bring you an exclusive preevent podcast series created to provide confirmed and prospective attendees with a preview of the 2018 BioProcess International Conference and Exhibition. Several conference speakers sat down with Dan Stanton, editor of BioProcess Insider, to share their expert perspectives and commentary on scientific and technological trends in topics that will be covered in five of the meeting’s seven program tracks.
In this special insert, we present summaries of those discussions along with information that should help you plan your week at the Biotech Week Boston and our event in particular. We all look forward to welcoming you to Boston this September.
Barry Walsh, Michael Keenan, and Howard Choi — KNect365 (a division of Informa)
Brian Caine — publisher of BioProcess International
Chris Johnson, Michael Kelly, and Victoria Biscoe — BioProcess International sales and marketing consultants
S. Anne Montgomery, Cheryl Scott, and Maribel Rios — BioProcess International editors
Dan Stanton — BioProcess Insider editor